Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Clinicopathological factors as...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Export Ready — 
Clinicopathological factors associated with novel prognostic markers for patients with triple negative breast cancer

Clinicopathological factors associated with novel prognostic markers for patients with triple negative breast cancer

Bibliographic Details
Main Authors: Anna Badowska-Kozakiewicz, Michał Budzik, Anna Liszcz, Maciej Sobieraj, Aleksandra Czerw, Maria Sobol, Janusz Patera, Andrzej Deptała
Format: Article
Language:English
Published: Termedia Publishing House 2018-11-01
Series:Archives of Medical Science
Subjects:
triple negative breast cancer
erythropoietin receptor
erythropoietin
immunohistochemical examination
Online Access:https://www.termedia.pl/Clinicopathological-factors-associated-with-novel-prognostic-markers-for-patients-with-triple-negative-breast-cancer,19,34132,1,1.html
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://www.termedia.pl/Clinicopathological-factors-associated-with-novel-prognostic-markers-for-patients-with-triple-negative-breast-cancer,19,34132,1,1.html

Similar Items

  • Immunohistochemical evaluation of osteopontin expression in triple-negative breast cancer
    by: Magdalena Niedolistek, et al.
    Published: (2020-04-01)
  • Medullary breast cancer is a predominantly triple-negative breast cancer – histopathological analysis and comparison with invasive ductal breast cancer
    by: Michał P. Budzik, et al.
    Published: (2019-07-01)
  • APPLICATION OF ERYTHROPOIETIN THETA IN THERAPY OF ANEMIA IN ONCOLOGIC PATIENTS
    by: O. A. GLADKOV, et al.
    Published: (2016-12-01)
  • Erythropoietin resistance in patients with regular hemodialysis in Sohag university hospital
    by: Nagwa S. Ahmed, et al.
    Published: (2023-06-01)
  • Effect of recombinant human erythropoietin and its combination with tamoxifen on viability of MCF-7 cell in three-dimensional culture
    by: Shujaaedin, Hareth Yahya Ahmed
    Published: (2019)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs